Television viewers in Middle Tennessee will begin to see new messages from Vanderbilt University Medical Center this week that build upon the “Promise of Discovery” theme to describe the Medical Center's work and mission.

New findings add to the understanding of how the enzyme COX-2 works, which is critical to the development of COX-2-targeted anti-inflammatory drugs.

VUMC's Strategic Marketing Department has received multiple awards in the 17th annual Digital Health Awards program.

After months transitioning clinics across Vanderbilt University Medical Center and training clinicians and staff, the move to the new medical coding and reporting system is complete.

Two Vanderbilt-Ingram Cancer Center (VICC) investigators — Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of VICC, and Valerie Jansen, M.D., Ph.D., medical oncology fellow — have received new cancer research grants awarded by Susan G. Komen, the world’s largest nonprofit funder of breast cancer research.

Vanderbilt’s Thomas Wang, M.D., left, Nancy Brown, M.D., and David Bader, Ph.D., explored the human determinants of cardiovascular disease and treatment at last week’s Flexner Discovery Lecture.